Ken Griffin Optimize Rx Corp Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Optimize Rx Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 21,800 shares of OPRX stock, worth $113,578. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,800
Previous 2,800
678.57%
Holding current value
$113,578
Previous $34,000
541.18%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding OPRX
# of Institutions
97Shares Held
13.6MCall Options Held
79.8KPut Options Held
41.4K-
First Light Asset Management, LLC Edina, MN1.83MShares$9.52 Million1.66% of portfolio
-
Divisadero Street Capital Management, LP Miami, FL1.32MShares$6.86 Million2.27% of portfolio
-
Black Rock Inc. New York, NY1.18MShares$6.12 Million0.0% of portfolio
-
Awm Investment Company, Inc. New York, NY1MShares$5.22 Million1.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA974KShares$5.07 Million0.0% of portfolio
About OptimizeRx Corp
- Ticker OPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 18,023,100
- Market Cap $93.9M
- Description
- OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patien...